http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20180003565-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4b3db7dd56b56cc6d94d0e0cccc38322
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A45D2044-007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2037-0007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0059
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-441
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0059
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A45D34-041
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M35-003
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-441
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A45D44-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A45D34-04
filingDate 2016-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07aabf30b832efc6def2087b3ce732bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4bac0690af3e11fa53280f8f0569f4b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8b1b40569e83d59f6031a51b28396b9
publicationDate 2018-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20180003565-A
titleOfInvention Applicators for treating skin conditions
abstract The applicator includes a discontinuous identification component and at least one therapeutic composition component. The discontinuous identification component is operably coupled to the electromagnetic energy query component and the discontinuous identification component is configured to determine the treatment state based on a query response to an electromagnetic energy stimulus that exhibits a greater absorbance difference than the target amount. Wherein at least one therapeutic composition component is operably coupled to a discontinuous component and wherein the at least one therapeutic composition component selectively treats the therapeutic composition on a portion of the skin in response to one or more inputs from a discontinuous component indicative of a desired therapeutic state Respectively.
priorityDate 2015-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012515063-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20040083372-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID485223053
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66868

Total number of triples: 29.